Drug
BMS-820836
BMS-820836 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 83.3%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
83.3%
Based on 5 completed trials
Completion Rate
83%(5/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(17%)
Phase Distribution
Ph phase_1
3
50%
Ph phase_2
3
50%
Phase Distribution
3
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
3(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
83.3%
5 of 6 finished
Non-Completion Rate
16.7%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Terminated(1)
Detailed Status
Completed5
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
83.3%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (50.0%)
Phase 23 (50.0%)
Trials by Status
completed583%
terminated117%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_2
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
NCT01369095
completedphase_2
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
NCT01309945
terminatedphase_2
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
NCT01361555
completedphase_1
Japanese Phase 1 Multiple Ascending Dose (MAD) Study
NCT01396252
completedphase_1
Multiple-Ascending Dose Study
NCT00892840
Clinical Trials (6)
Showing 6 of 6 trials
NCT01369095Phase 2
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
NCT01309945Phase 2
Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
NCT01361555Phase 2
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
NCT01396252Phase 1
Japanese Phase 1 Multiple Ascending Dose (MAD) Study
NCT00892840Phase 1
Multiple-Ascending Dose Study
NCT00964912Phase 1
Single Dose Study of BMS-820836
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6